Viridian Therapeutics (Nasdaq: VRDN) announced that the U.S. Food and Drug Administration has approved Lumvoa (veligrotug-vvze) for the treatment of ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

FDA

Viridian Therapeutic (VRDN) PT Raised to $43 at WedbushJune 29, 2026 12:25 PM William Blair on Viridian Therapeutic (VRDN): 'We came away from the call incrementally more confident'June 29, 2026 12:25 PM